<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36103880</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2666-3791</ISSN><JournalIssue CitedMedium="Internet"><Volume>3</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Cell reports. Medicine</Title><ISOAbbreviation>Cell Rep Med</ISOAbbreviation></Journal><ArticleTitle>Disentangling the cognitive, physical, and mental health sequelae of COVID-19.</ArticleTitle><Pagination><StartPage>100750</StartPage><MedlinePgn>100750</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100750</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xcrm.2022.100750</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2666-3791(22)00299-3</ELocationID><Abstract><AbstractText>As COVID-19 cases exceed hundreds of millions globally, many survivors face cognitive challenges and prolonged symptoms. However, important questions about the cognitive effects of COVID-19 remain unresolved. In this cross-sectional online study, 478 adult volunteers who self-reported a positive test for COVID-19 (mean&#xa0;= 30&#xa0;days since most recent test) perform significantly worse than pre-pandemic norms on cognitive measures of processing speed, reasoning, verbal, and overall performance, but not short-term memory, suggesting domain-specific deficits. Cognitive differences are even observed in participants who did not require hospitalization. Factor analysis of health- and COVID-related questionnaires reveals two clusters of symptoms-one that varies mostly with physical symptoms and illness severity, and one with mental health. Cognitive performance is positively correlated with the global measure encompassing physical symptoms, but not the one that broadly describes mental health, suggesting that the subjective experience of "long COVID" relates to physical symptoms and cognitive deficits, especially executive dysfunction.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wild</LastName><ForeName>Conor J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Western Institute for Neuroscience, Western University, London, ON N6A 3K7, Canada; Department of Physiology and Pharmacology, Western University, London, ON N6A 3K7, Canada. Electronic address: cwild@uwo.ca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norton</LastName><ForeName>Loretta</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Western Institute for Neuroscience, Western University, London, ON N6A 3K7, Canada; Department of Psychology, King's University College, Western University, London, ON N6A 3K7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menon</LastName><ForeName>David K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge CB2 2QQ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ripsman</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Department of Neurology, University of British Columbia, Vancouver, BC V6T 2B5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swartz</LastName><ForeName>Richard H</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Medicine (Neurology), Hurvitz Brain Sciences Program, Sunnybrook Health Sciences Center, University of Toronto, Toronto, ON M4N 3M5, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Owen</LastName><ForeName>Adrian M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Western Institute for Neuroscience, Western University, London, ON N6A 3K7, Canada; Department of Physiology and Pharmacology, Western University, London, ON N6A 3K7, Canada; Department of Psychology, Western University, London, ON N6A 3K7, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep Med</MedlineTA><NlmUniqueID>101766894</NlmUniqueID><ISSNLinking>2666-3791</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008603" MajorTopicYN="Y">Mental Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cognition</Keyword><Keyword MajorTopicYN="N">cross-sectional online study</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">mental health</Keyword><Keyword MajorTopicYN="N">physical health</Keyword></KeywordList><CoiStatement>Declaration of interests The cognitive tests used in this study are marketed by Cambridge Brain Sciences (CBS), of which A.M.O. is the chief scientific officer. Under the terms of the existing licensing agreement, A.M.O. and his collaborators are free to use the platform at no cost for their scientific studies, and that such research projects neither contribute to, nor are influenced by, the activities of the company. C.J.W. provides consulting services to CBS. Consequently, there is no overlap between the present study and the activities of CBS, nor was there any cost to the authors, funding bodies, or participants who were involved in the study. R.H.S. is founder and owner of FollowMD, Inc., a vascular risk-reduction clinic. The authors declare no other competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36103880</ArticleId><ArticleId IdType="pmc">PMC9448696</ArticleId><ArticleId IdType="doi">10.1016/j.xcrm.2022.100750</ArticleId><ArticleId IdType="pii">S2666-3791(22)00299-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wild C.J., Norton L., Swartz R.H., Owen A.M. Cognitive testing and questionnaire data from survivors of COVID-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.5683/SP2/ZQR9QQ</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R., Jolly A.E., Grant J.E., Patrick F., Mazibuko N., Williams S.C., Barnby J.M., Hellyer P., Mehta M.A. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C., et al. 2020. Brain Behavior and Immunity High Frequency of Cerebrospinal Fluid Autoantibodies in COVID-19 Patients with Neurological Symptoms.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., Thomas N., Ellul M.A., Davies N.W.S., Pollak T.A., Tenorio E.L., Sultan M., Easton A., Breen G., Zandi M., et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatr. 2020;7:875&#x2013;882.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., Collange O., Boulay C., Fafi-Kremer S., Ohana M., et al. Neurologic features in severe SARS-CoV-2 infection. N.&#xa0;Engl. J. Med. 2020;382:2268&#x2013;2270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanin L., Saraceno G., Panciani P.P., Fontanella M.M. 2020. SARS-CoV-2 Can Induce Brain and Spine Demyelinating Lesions; pp. 1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197630</ArticleId><ArticleId IdType="pubmed">32367205</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.-H., Perl D.P., Nair G., Li W., Maric D., Murray H., Dodd S.J., Koretsky A.P., Watts J.A., Cheung V., et al. Microvascular injury in the brains of patients with covid-19. N.&#xa0;Engl. J. Med. 2021;384:481&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Honarmand K., Malik S., Wild C., Gonzalez-Lara L.E., McIntyre C.W., Owen A.M., Slessarev M. Feasibility of a web-based neurocognitive battery for assessing cognitive function in critical illness survivors. PLoS One. 2019;14 e0215203&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6461230</ArticleId><ArticleId IdType="pubmed">30978210</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande P.P., Girard T.D., Jackson J.C., Morandi A., Thompson J.L., Pun B.T., Brummel N.E., Hughes C.G., Vasilevskis E.E., Shintani A.K., et al. Long-term cognitive impairment after critical illness. N.&#xa0;Engl. J. Med. 2013;369:1306&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3922401</ArticleId><ArticleId IdType="pubmed">24088092</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohler J., Borchers F., Endres M., Weiss B., Spies C., Emmrich J.V. Cognitive deficits following intensive care. Dtsch. Arztebl. Int. 2019;116:627&#x2013;634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6829162</ArticleId><ArticleId IdType="pubmed">31617485</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelland G.W. Gluten-induced cognitive impairment (&#x201c;brain fog&#x201d;) in coeliac disease. J.&#xa0;Gastroenterol. Hepatol. 2017;32:90&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">28244662</ArticleId></ArticleIdList></Reference><Reference><Citation>Ocon A.J. Caught in the thickness of brain fog: exploring the cognitive symptoms of Chronic Fatigue Syndrome. Front. Physiol. 2013;4:63&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3617392</ArticleId><ArticleId IdType="pubmed">23576989</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovalchuk A., Kolb B. Chemo brain: from discerning mechanisms to lifting the brain fog&#x2014;an aging connection. Cell Cycle. 2017;16:1345&#x2013;1349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5539816</ArticleId><ArticleId IdType="pubmed">28657421</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Long covid: doctors call for research and surveillance to capture disease. BMJ. 2020;370:m3586.</Citation><ArticleIdList><ArticleId IdType="pubmed">32933925</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein M.F., Folstein S.E., McHugh P.R. &#x201c;Mini-mental state&#x201d;. A practical method for grading the cognitive state of patients for the clinician. J.&#xa0;Psychiatr. Res. 1975;12:189&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine Z.S., Phillips N.A., B&#xe9;dirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J.&#xa0;Am. Geriatr. Soc. 2005;53:695&#x2013;699.</Citation><ArticleIdList><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Amalakanti S., Arepalli K.V.R., Jillella J.P. Cognitive assessment in asymptomatic COVID-19 subjects. VirusDisease. 2021;32:146&#x2013;149. doi: 10.1007/s13337-021-00663-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-021-00663-w</ArticleId><ArticleId IdType="pmc">PMC7883942</ArticleId><ArticleId IdType="pubmed">33614860</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay M.R.J., Low Y.H., Lim C.C.T., Umapathi T., Thio J.M.L., Lui W.L., Chan W.L.W., Chua K.S.G. Covert subclinical neurocognitive sequelae during the rehabilitation course of severe coronavirus disease 2019. Am. J. Phys. Med. Rehabil. 2021;100:39&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">33109908</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaud V., Crottaz-Herbette S., Dunet V., Vaucher J., Bernard-Valnet R., Du Pasquier R., Bart P.A., Clarke S. Pattern of cognitive deficits in severe COVID-19. J.&#xa0;Neurol. Neurosurg. Psychiatry. 2020;92:567&#x2013;568. 325173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8053331</ArticleId><ArticleId IdType="pubmed">33219042</ArticleId></ArticleIdList></Reference><Reference><Citation>Negrini F., Ferrario I., Mazziotti D., Berchicci M., Bonazzi M., de Sire A., Negrini S., Zapparoli L. Neuropsychological features of severe hospitalized coronavirus disease 2019 patients at clinical stability and clues for postacute rehabilitation. Arch. Phys. Med. Rehabil. 2021;102:155&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7521874</ArticleId><ArticleId IdType="pubmed">32991870</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Cassar M.P., Tunnicliffe E.M., Filippini N., Griffanti L., Alfaro-Almagro F., Okell T., Sheerin F., Xie C., Mahmod M., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Lu S., Chen J., Wei N., Wang D., Lyu H., Shi C., Hu S. The landscape of cognitive function in recovered COVID-19 patients. J.&#xa0;Psychiatr. Res. 2020;129:98&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R., Dini M., Groppo E., Rosci C., Reitano M.R., Bai F., Poletti B., Brugnera A., Silani V., D'Arminio Monforte A., Priori A. Long-lasting cognitive abnormalities after COVID-19. Brain Sci. 2021;11:235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7917789</ArticleId><ArticleId IdType="pubmed">33668456</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside D.M., Oleynick V., Holker E., Waldron E.J., Porter J., Kasprzak M. Neurocognitive deficits in severe COVID-19 infection: case series and proposed model. Clin. Neuropsychol. 2021;35:799&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">33487098</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M.S., Malsy J., P&#xf6;ttgen J., Seddiq Zai S., Ufer F., Hadjilaou A., Schmiedel S., Addo M.M., Gerloff C., Heesen C., et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2 fcaa205&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A., Vanderlind W.M., Alexopoulos G.S., Fridman C.B., Perlis R.H., Gunning F.M. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. medRxiv. 2020 doi: 10.1101/2020.10.28.20221887. Preprint at.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.28.20221887</ArticleId><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouqui P., Amrane S., Million M., Cortaredona S., Parola P., Lagier J.C., Raoult D. Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int. J. Infect. Dis. 2021;102:233&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604151</ArticleId><ArticleId IdType="pubmed">33130200</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobin M.J., Laghi F., Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am. J. Respir. Crit. Care Med. 2020;202:356&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7397783</ArticleId><ArticleId IdType="pubmed">32539537</ArticleId></ArticleIdList></Reference><Reference><Citation>Areza-Fegyveres R., Kairalla R.A., Carvalho C.R.R., Nitrini R. Cognition and chronic hypoxia in pulmonary diseases. Dement. Neuropsychol. 2010;4:14&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5619525</ArticleId><ArticleId IdType="pubmed">29213655</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilyukov R.G., Nikolov M.S., Pencheva V.P., Petrova D.S., Georgiev O.B., Mondeshki T.L., Milanova V.K. Cognitive impairment and affective disorders in patients with obstructive sleep apnea syndrome. Front. Psychiatry. 2018;9:357&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6091233</ArticleId><ArticleId IdType="pubmed">30131730</ArticleId></ArticleIdList></Reference><Reference><Citation>Gayete S., Gin&#xe9; A., Miret M., Ayuso-Mateos J.L., Haro J.M., Olaya B. Cognitive function associated with different diagnoses of anxiety disorders over the lifespan: results from a Spanish representative sample. J.&#xa0;Anxiety Disord. 2020;75:102296.</Citation><ArticleIdList><ArticleId IdType="pubmed">32866758</ArticleId></ArticleIdList></Reference><Reference><Citation>Semkovska M., Quinlivan L., O'Grady T., Johnson R., Collins A., O'Connor J., Knittle H., Ahern E., Gload T. Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatr. 2019;6:851&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pubmed">31422920</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsey C.M., Schmitter-Edgecombe M. Using actigraphy to predict the ecological momentary assessment of mood, fatigue, and cognition in older adulthood: mixed-Methods study. JMIR Aging. 2019;2:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6715102</ArticleId><ArticleId IdType="pubmed">31518282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagogianni C., Thomas S., Lincoln N. Examining the relationship between fatigue and cognition after stroke: a systematic review. Neuropsychol. Rehabil. 2018;28:57&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">26787096</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatr. 2021;8:130&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyraz B.&#xc7;., Poyraz C.A., Olgun Y., G&#xfc;rel &#xd6;., Alkan S., &#xd6;zdemir Y.E., Balkan &#x130;.&#x130;., Karaali R. Psychiatric morbidity and protracted symptoms after COVID-19. Psychiatry Res. 2021;295:113604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7695976</ArticleId><ArticleId IdType="pubmed">33296818</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., De Lorenzo R., Conte C., Poletti S., Vai B., Bollettini I., Melloni E.M.T., Furlan R., Ciceri F., Rovere-Querini P., et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav. Immun. 2020;89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldati A.B., Almeida C., Lima M., Araujo A., Araujo-Leite M.A., Silva M.T.T. Telephone Screening of Cognitive Status (TICS) in severe COVID-19 patients: utility in the era of social isolation. eNeurologicalSci. 2021;22:100322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7817447</ArticleId><ArticleId IdType="pubmed">33495738</ArticleId></ArticleIdList></Reference><Reference><Citation>Hays R.D., Sherbourne C.D., Mazel R.M. The rand 36-item health survey 1.0. Health Econ. 1993;2:217&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">8275167</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K., Spitzer R.L., Williams J.B.W. The patient health questionnaire-2: validity of a two-item depression screener. Med. Care. 2003;41:1284&#x2013;1292.</Citation><ArticleIdList><ArticleId IdType="pubmed">14583691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruine de Bruin W. Age differences in COVID-19 risk perceptions and mental health: evidence from a national U.S. Survey conducted in march 2020. J.&#xa0;Gerontol.: Ser. Bibliogr. 2021;76:E24&#x2013;E29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7542924</ArticleId><ArticleId IdType="pubmed">32470120</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong A.S.F., Pearson R.M., Adams M.J., Northstone K., Tilling K., Smith D., Fawns-Ritchie C., Bould H., Warne N., Zammit S., et al. Mental health before and during the COVID-19 pandemic in two longitudinal UK population cohorts. Br. J. Psychiatry. 2021;218:334&#x2013;343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7844173</ArticleId><ArticleId IdType="pubmed">33228822</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild C.J., Nichols E.S., Battista M.E., Stojanoski B., Owen A.M. Dissociable effects of self-reported daily sleep duration on high-level cognitive abilities. Sleep. 2018;41:1&#x2013;11. doi: 10.1093/sleep/zsy182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/zsy182</ArticleId><ArticleId IdType="pmc">PMC6289236</ArticleId><ArticleId IdType="pubmed">30212878</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Highfield R.R., Parkin B.L., Owen A.M. Fractionating human intelligence. Neuron. 2012;76:1225&#x2013;1237.</Citation><ArticleIdList><ArticleId IdType="pubmed">23259956</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization W.H. WHO R&amp;D Blueprint: Novel Coronavirus: Outline of Trial Designs for Experimental Therapeutics. 2020. https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/grc-740953</Citation></Reference><Reference><Citation>Kroenke K., Spitzer R.L., Williams J.B.W., Monahan P.O., L&#xf6;we B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann. Intern. Med. 2007;146:317&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">17339617</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo I.-K., Johnson R.A. A new family of power transformations to improve normality or symmetry. Biometrika. 2000;87:954&#x2013;959. http://www.jstor.org/stable/2673623</Citation></Reference><Reference><Citation>Selya A.S., Rose J.S., Dierker L.C., Hedeker D., Mermelstein R.J. A practical guide to calculating Cohen&#x2019;s f 2, a measure of local effect size, from PROC MIXED. Front. Psychol. 2012;3:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3328081</ArticleId><ArticleId IdType="pubmed">22529829</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman D.W. A note on preliminary tests of equality of variances. Br. J. Math. Stat. Psychol. 2004;57:173&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">15171807</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>